<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease (also known as morbus <z:e sem="disease" ids="C0004943" disease_type="Disease or Syndrome" abbrv="">Behcet</z:e> or Admantiades-<z:e sem="disease" ids="C0004943" disease_type="Disease or Syndrome" abbrv="">Behcet syndrome</z:e>) is a <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0002633'>vasculitis</z:hpo> mainly characterized by recurrent mucocutaneous lesions and sight threatening <z:hpo ids='HP_0000554'>uveitis</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>It may also involve joints, vessels of <z:hpo ids='HP_0000001'>all</z:hpo> sizes and the central <z:mp ids='MP_0008912'>nervous</z:mp> system </plain></SENT>
<SENT sid="2" pm="."><plain>Because of its severe morbidity and considerable mortality early diagnosis and treatment is important </plain></SENT>
<SENT sid="3" pm="."><plain>Treatment and prognosis of this disorder have profited considerably in recent years following the introduction of biologic agents </plain></SENT>
<SENT sid="4" pm="."><plain>This article summarizes the current state of knowledge and emphasizes the important role of the ophthalmologist in the diagnosis and therapy of <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease </plain></SENT>
</text></document>